Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.


Published on .

In the last few months, American Home Products Corp. has been a takeover target of SmithKline Beecham and Glaxo Wellcome, but both potential mergers quickly fell through.

AHP's prescription antidepressant Effexor has achieved rapid growth, its giant Premarin hormone therapy has continued strong sales and over-the-counter Advil has enjoyed modest sales gains. Still, AHP suffered from questions about the safety of its prescription obesity treatment, Redux, that resulted in its removal from the market.

Most Popular
In this article: